EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Dysfunction in Cardiomyopathy and Heart Failure: From Energetic Collapse to Therapeutic Opportunity

Nikola Pavlović iD, Petar Todorović iD, Mirko Maglica iD, Marko Kumrić iD, Katarina Vukojević iD, Zenon Pogorelić iD, Joško Božić iD

Biomolecules · 09.11.2025 · 15 (11) · 1572

DOI: 10.3390/biom15111572 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 09.11.2025. Verfasst von Nikola Pavlović und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies, Mitochondria, Heart, Mitochondria. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heart’s relentless contractile activity depends critically on mitochondrial function to meet its extraordinary bioenergetic demands. Mitochondria, through oxidative phosphorylation, not only supply ATP but also regulate metabolism, calcium homeostasis, and apoptotic signaling, ensuring cardiomyocyte viability and cardiac function. Mitochondrial dysfunction is a hallmark of cardiomyopathies and heart failure, characterized by impaired oxidative phosphorylation, excessive production of reactive oxygen species (ROS), dysregulated calcium handling, and disturbances in mitochondrial dynamics and mitophagy. These defects culminate in energetic insufficiency, cellular injury, and cardiomyocyte death, driving heart disease progression. Diverse cardiomyopathy phenotypes exhibit distinct mitochondrial pathologies, from acute ischemia-induced mitochondrial collapse to chronic remodeling seen in dilated, hypertrophic, restrictive, and primary mitochondrial cardiomyopathies. Mitochondria also orchestrate cell death and inflammatory pathways that worsen cardiac dysfunction. Therapeutic strategies targeting mitochondrial dysfunction, including antioxidants, modulators of mitochondrial biogenesis, metabolic therapies, and innovative approaches such as mitochondrial transplantation, show promise but face challenges in clinical translation. Advances in biomarker discovery and personalized medicine approaches hold promise for optimizing mitochondrial-targeted therapies. Unlike previous reviews that examined these pathways or interventions individually, this work summarizes insights into mechanisms with emerging therapeutic strategies, such as SGLT2 inhibition in HFpEF, NAD+ repletion, mitochondrial transplantation, and biomarker-driven precision medicine, into a unified synthesis. This framework underscores the novel contribution of linking basic mitochondrial biology to translational and clinical opportunities in cardiomyopathy and heart failure. This review synthesizes the current understanding of mitochondrial biology in cardiac health and disease, delineates the molecular mechanisms underpinning mitochondrial dysfunction in cardiomyopathy and heart failure, and explores emerging therapeutic avenues aimed at restoring mitochondrial integrity and improving clinical outcomes in cardiac patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiomyopathiesMitochondria, HeartMitochondriaHumansAnimalsEnergy MetabolismReactive Oxygen SpeciesMyocytes, Cardiac

Stichwörter der Autor:innen

bioenergeticscardiomyopathyheart failuremitochondrial dynamicsmitochondrial dysfunction

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pathophysiology, University of Split School of Medicine, 21000 Split, Croatia.
  • Laboratory for Cardiometabolic Research, University of Split School of Medicine, 21000 Split, Croatia.
  • Department of Anatomy, Histology and Embryology, University of Split School of Medicine, 21000 Split, Croatia.
  • Department of Anatomy, School of Medicine, University of Mostar, 88000 Mostar, Bosnia and Herzegovina.
  • Department of Otorhinolaryngology, University Hospital of Split, 21000 Split, Croatia.
  • Mediterranean Institute for Life Sciences, University of Split, 21000 Split, Croatia.

ORCID-Profile: Nikola Pavlović, Petar Todorović, Mirko Maglica, Marko Kumrić, Katarina Vukojević, Zenon Pogorelić, Joško Božić

Zitieren

APA

Pavlović, N., Todorović, P., Maglica, M., Kumrić, M., Vukojević, K., Pogorelić, Z., & Božić, J. (2025). Mitochondrial Dysfunction in Cardiomyopathy and Heart Failure: From Energetic Collapse to Therapeutic Opportunity. Biomolecules, 15(11), 1572. https://doi.org/10.3390/biom15111572

Vancouver

Pavlović N, Todorović P, Maglica M, Kumrić M, Vukojević K, Pogorelić Z, et al. Mitochondrial Dysfunction in Cardiomyopathy and Heart Failure: From Energetic Collapse to Therapeutic Opportunity. Biomolecules. 2025;15(11):1572. doi:10.3390/biom15111572

BibTeX
@article{Pavlovi2025,
  author = {Pavlović, Nikola and Todorović, Petar and Maglica, Mirko and Kumrić, Marko and Vukojević, Katarina and Pogorelić, Zenon and Božić, Joško},
  title = {Mitochondrial Dysfunction in Cardiomyopathy and Heart Failure: From Energetic Collapse to Therapeutic Opportunity},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {11},
  pages = {1572},
  doi = {10.3390/biom15111572}
}
Kostenlos starten →